U.S. Physical Therapy Inc. (USPH) Moves Higher on Volume Spike for April 07

U.S. Physical Therapy Inc. (USPH) traded on unusually high volume on Apr. 07, as the stock
gained 2.02% to close at $63.15. On the day, U.S. Physical Therapy Inc. saw 125,702 shares trade hands on 990 trades.
Considering that the stock averages only a daily volume of 72,921 shares a day over the last month, this represents a pretty significant bump in volume over the norm.

Generally speaking, when a stock experiences a sudden spike in trading volume, it may be seen as a bullish signal for investors. An increase in volume means more market awareness for the
company, potentially setting up a more meaningful move in stock price. The added volume also provides a level of support and stability for price advances.

The stock has traded between $78.00 and $46.39 over the last 52-weeks, its 50-day SMA is now $70.40, and its 200-day SMA $64.94. U.S. Physical Therapy Inc.
has a P/B ratio of 4.42. It also has a P/E ratio of 31.9.

US Physical Therapy Inc operates outpatient physical and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, preventative care, and rehabilitation of injured workers among others.

Headquartered in Houston, TX, U.S. Physical Therapy Inc. has 3,400 employees and is currently under the leadership of CEO Christopher J. Reading.

For a complete fundamental analysis analysis of U.S. Physical Therapy Inc., check out Equities.com’s Stock Valuation Analysis report
for USPH

Want to invest with the experts? Subscribe to Equities Premium newsletters today! Visit http://www.equitiespremium.com/ to
learn more about Guild Investment’s Market Commentary and Adam Sarhan’s
Find Leading Stocks

To get more information on U.S. Physical Therapy Inc. and to follow the company’s latest updates, you can visit the company’s profile page here:
USPH’s Profile
. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s
. Also, don’t forget to sign-up for our daily
email newsletter
to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Source link












Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 3, 2017




(Exact name of registrant as specified in its charter)










(State or other jurisdiction

of incorporation or organization)



File Number)


(I.R.S. Employer

Identification No.)



1300 West Sam Houston Parkway South,

Suite 300, Houston, Texas



(Address of Principal Executive Offices)


(Zip Code)

Registrant’s telephone number, including area code: (713) 297-7000



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))


Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))






Item 3.01   Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.




    On April 3, 2017, U.S. Physical Therapy, Inc. (the “Company”) received a notice from the New York Stock Exchange (the “NYSE”) indicating that the Company is not in compliance with the NYSE’s continued listing requirements under the timely filing criteria outlined in Section 802.01E of the NYSE Listed Company Manual as a result of the Company’s failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2016 (the “Form 10-K”).


    As reported by the Company in its Form 12b-25 filed with the Securities and Exchange Commission (the “SEC”) on March 17, 2017, the Company was unable to file its Form 10-K within the prescribed time period without unreasonable effort or expense. The extension period provided under Rule 12b-25 expired on March 31, 2017. As reported by the Company in its Form 8-K filed with the SEC on March 31, 2017, the Company was unable to file its Form 10-K within the extension period because it needs additional time to complete its review of the appropriate accounting treatment for redeemable non-controlling interests of its acquired partnerships.


    The NYSE informed the Company that, under the NYSE’s rules, the Company will have six months from March 16, 2017 to file the Form 10-K with the SEC. The Company can regain compliance with the NYSE continued listing requirements at any time before that date by filing the Form 10-K with the SEC. The Company continues to work diligently to complete the preparation of its consolidated financial statements in order to be in a position to file the Form 10-K with the SEC as soon as possible in April. If the Company fails to file the Form 10-K before the NYSE’s six-month compliance deadline, the NYSE may grant, at its sole discretion, an extension of up to six additional months for the Company to regain compliance, depending on the specific circumstances.






Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.








Dated: April 7, 2017













Lawrance W. McAfee







Chief Financial Officer







(duly authorized officer and principal financial

           and accounting officer)

Source link